Tom Hayday

Tom Hayday is a co-founder and Chief Research Officer at IMU Biosciences since May 2021, bringing extensive expertise in biomedical research. Previously, Tom served as a Postdoctoral Research Associate at King's College London, where work concentrated on high-throughput immune-phenotyping and the innate biology of adaptive antigen receptors from April 2020 to September 2021. Earlier roles include managing the Flow Cytometry Facility at King's College London from January 2010 to September 2015. Tom holds a Ph.D. in Biomedical and Translational Science from King's College London (2015-2019) and a Bachelor's Degree in Biomedical Sciences from Birkbeck, University of London (2010-2014).